CONTENTS
About the ReportStatement of the Board of DirectorsMessage from the ChairmanPerformance Highlights in 2024
About UsBusiness LayoutCorporate CulturesDevelopment trategysDevelopment HistoryAwards and Recognitions
Environmental ManagementEnvironmental Management SystemEnvironmental Risk ManagementPollution PreventionWaste Water ManagementWaste Gas ManagementWaste ManagementNoise Management
Innovation EmpowermentScienti?c Research FrameworkR&D investmentRecently Introduced ProductsIntellectual Property ProtectionExperimental EthicsCollaborative Industry AdvancementAcademic ExchangeStandard EstablishmentSchool-Enterprise CooperationTraining and Talent CultivationAccessibility of Medical Services
Corporate GovernanceGovernance StructureBoard OperationInformation DisclosureInvestor Relations ManagementInvestor ReturnsMarket Capitalization Management
Sustainability ManagementESG Strategic PlanningESG Management SystemStakeholders' CommunicationMateriality Assessment
Resource Management
Water Resource ManagementEnergy ManagementGreen ProductionGreen Oce PracticesClimate Action
Product Responsibility
Quality ManagementCustomer ServiceSustainable Supply ChainEmployee DevelopmentEmployees Rights and InterestsCultivation and DevelopmentWelfare and CareOccupational Health and SafetyServe The SocietyInternational Aid InitiativesMedical DonationPublic Welfare and CharityScienti?c Popularization
Risk Management and ControlCompliance and Internal Control ManagementRelated Party Transactions and ControlAnalysis of Public OpinionAnti-Fraud and Anti-Corruption MeasuresAnti-Competitive PracticesReporting MechanismInformation SecurityAppendix
Environmental
Governance
Social
About the ReportStatement of the Board of Directors
The Board of Directors of Eyebright Medical assumeoverall responsibility for the accuracy, completeness, andtimeliness of the content and information disclosed in thisreport. As the core decision-making body of corporategovernance, the Board is fully and deeply responsiblefor matters related to Environmental (E), Social (S), andGovernance (G).In the formulation of the ESG governance strategy, theBoard has developed an ESG strategic roadmap alignedwith the Company’s long term objectives. When assessingESG-related impacts, risks, and opportunities, the Boardemploys a rigorous and professional approach, helpingidentify risks early and seize opportunities, ensuring asolid foundation for the Company's stable development.The board of directors has established a comprehensiveoversight mechanism, closely monitoring the progress ofvarious ESG initiatives to ensure that strategic decisionscan be effectively implemented. At the same time, theboard continuously tracks the progress of ESG-relatedgoals and adjusts strategies and action plans in a timelymanner based on actual conditions, ensuring that theCompany continues to make positive progress in the ESG?eld.The Company's board of directors places great importanceon information disclosure. Each year, the board conductsa rigorous review of the Company's ESG report toensure that the report accurately and truthfully reflectsthe Company's the effectiveness and reliability of theCompany's ESG e?orts.This report provides a detailed disclosure of EyebrightMedical's progress and achievements in ESG work for2024, having been reviewed and approved at the meetingof the Board of Directors.
Report OverviewEyebright Medical Technology (Beijing) Co., Ltd. (hereinafter referred to as "Eyebright Medical," "the Company,"or "we") has systematically established an ESG management framework to achieve an in-depth integration ofshareholder rights protection and sustainable corporate development.Report ScopeThe scope of this report encompasses Eyebright Medical and its aliated subsidiaries.Reporting PeriodThis report covers the period from January 1, 2024, to December 31, 2024.Information SourcesThe data used in this report is sourced from public data released. Unless otherwise noted, all non-?nancial datafor 2024 is drawn from the Company’s headquarters. The Company assures that the content of this report doesnot contain any false records, misleading statements, or material omissions.Important NoticeThis report has been reviewed and approved by the Company's Board of Directors for public disclosure. TheCompany and the board of directors assure that the content of this report does not contain any false records,misleading statements, or material omissions.Basis for CompilationThe Global Sustainability Standards Board - "Global Reporting Initiative"China Enterprise Reform and Development Research Association - "China Enterprise Sustainable DevelopmentReport Guidelines (CASS-ESG 6.0)"National Standard of China - "Guidelines for the Preparation of Social Responsibility Reports" (GB/T36001-2015)International Organization for Standardization - "ISO 26000: Guidance on Social Responsibility" (2010)Shanghai Stock Exchange - "Self-Regulatory Guidelines No. 1 for Listed Companies on the Sci-Tech InnovationBoard: Standard Operations"Guidelines No. 14 of Shanghai Stock Exchange for Self-Regulation of Listed Companies- SustainableDevelopment Reports (Trial)Guidelines No. 13 of Shanghai Stock Exchange for Self-Regulation of Listed Companies on the Sci-TechInnovation Board - Preparation of Sustainable Development ReportsUnited Nations - "Guidelines for Corporate Action on the Sustainable Development Goals (SDGs)"Access InformationThe electronic version of the Report is available for downloading from the Eyebright Medical officialwebsite(www.ebmedical.com) and the Shanghai Stock Exchange website (www.sse.com.cn).For any questions or suggestions regarding the report, please contact us via: investors@ebmedical.com or（
）10-89748322. In case of any discrepancy or inconsistency in the versions, the Chinese version shall prevail.
2024 Environmental, Social and Governance Report
Message from the Chairman
Dear valued partners and friends from all walks oflife,Warm greetings to everyone!In 2024, China's healthcare reform maintainsdeepening momentum as systemic overhauls—spanning centralized medical device procurementand dynamic reimbursement list updates—establishstrategic frameworks steering industry evolution.This policy-market synergy drives dual upgradingof demand-supply dynamics amid intensifyingcompetition across the sector.Under the leadership of the Board, Eyebright Medicalhas proactively aligned with China's 'high-qualitydevelopment' policy directives, maintaining sustainedgrowth through its dual-driven strategy of "Medical+ Consumer" and accelerated global expansioninitiatives.In 2024, the Company achieved an operatingrevenue of RMB 1,410.02 million, representing ayear-on-year growth of 48.24% and a three-yearCAGR of 55.99%. The net profit excluding non-recurring gains and losses was RMB 390.08 million,re?ecting a year-on-year increase of 35.08% and athree-year CAGR of 37.00%.In product innovation, Eyebright Medical remainsunwavering in its mission to advance China's high-end ophthalmic medical device sector through
cutting-edge R&D. The aspheric diffractivemultifocal intraocular lens has now been includedin the National Centralized Procurement Program,increasing sales that accelerate domestic substitutionto meet high-end consumer demands. In myopiamanagement and control, the Company has beencontinuously refining and upgrading its proprietarytechnologies. Products like orthokeratology lenses,RGP lenses, and defocus glasses o?er comprehensivemyopia management solutions. In the consumervision care sector, the Company and its subsidiarieshave harnessed advantages to cutting - edgetechnological innovations in contact lens. They havebridged critical domestic gaps in high - end materialsand advanced manufacturing processes. Moreover,the gradual increase in production capacity hasreduced operational costs and become a new enginefor growth.The Company is exploring international channels byestablishing a wholly-owned subsidiary in Hong Kongto advance toward becoming a globally influentialophthalmic enterprise. It is seeking long-termpartnerships with renowned hospitals, key opinionleaders, and leading researchers across the world."To be a respected listed company" is a principle Ihave always emphasized. Over the past year, wehave actively fulfilled our social responsibilitiesby donating intraocular lenses, viscoelastic, andsurgical instruments for cataract surgeries in various
regions, including Henan, Qinghai, Gansu, Shandong,Xinjiang, and Tibet, bringing light and hope to thosein need. We also participated in international aidprojects, providing vision care to patients in countriessuch as Venezuela, Equatorial Guinea, Uzbekistan,Kyrgyzstan, Ethiopia, Zimbabwe, Tajikistan, Senegal,and Mauritania.Additionally, we have made numerous donationsto vulnerable groups and conducted ophthalmiceducation workshops for children, youth, andseniors, demonstrating our commitment to corporateresponsibility.Amid fierce market competition, Eyebright Medicalhas sustained resilient growth, underpinned bythe enduring trust and strategic alignment of itsshareholders. As we enter 2025, the Companyrearms its commitment to long-term value creationthrough high-quality development, and continuesto deepen our focus in the ophthalmic medical ?eld.We aim to reach new heights in advanced medicaltechnology, provide superior products for patients,and deliver strong performance for our investors. Letus work together to create a brighter future!
Eyebright Medical Technology (Beijing) Co., Ltd.
April 2025
“
Twin Growth Engines Ignite a New Journey: Setting Sail for Global Horizons
2024 Environmental, Social and Governance Report
Performance Highlight in 2024
Business Performance
Operating Revenue RMB1,410.02Million|Y-O-Y Growth
48.24%
Net Income Attributable to Shareholders RMB
388.40
Million|Y-O-Y Growth
27.77%
Net Income Excluding Non-recurring Items RMB
390.08
Million|Y-O-Y Growth
35.08%
Total Assets RMB3,496.97 MillionBasic Earnings per Share RMB
2.05
Equity Attributable to Shareholders RMB2,409.50MillionWeighted Average Return on Equity
17.32%
Innovation Empowerment
Research and Development Personnel
R&D Investment RMB
MillionPatents Applied
Patents Granted
Total Patents Applied
Total Authorized and Valid Patents
Participation in Standard Formulation and Industry Report Compilation
Product Quality
External Audits Conducted
timesNational Supervision Pass Rate100%Total Quality and Safety Training Sessions Held Nearly
times
Employee DevelopmentTotal Employees2,294| Y-O-Y Growth
10.61%
Percentage of Female Employees58%Percentage of Female Executives50%Cash Paid to Employees RMB
Million | Y-O-Y Growth
64.78%
Training Sessions Conducted
Total Training Duration28,338 HoursTotal Number of Participants in Training4,595
Employees with Equity Incentives
Total Incentivized Shares206,982 Shares
Community ontributions and Social Recognition
Taxes Paid RMB
163.62
MillionHosted or Participated in Science Popularization and Charity Activities
Total Donations in Goods Nearly RMB
1.43
MillionTotal Honors Received Throughout the Year Over
Honors
Governance Performace
Total Board and Committee Meetings Held
Disclosed Regular Reports
Disclosed Temporary Announcements
Two Consecutive Years of Information Disclosure Rating GradeAEarning Calls Brie?ngs Held
NoInsider TradingNo Correction Announcements
2024 Environmental, Social and Governance Report
About
Eyebright Medical Technology (Beijing) Co.,Ltd. is a national high-tech enterprise anda national-level specialized and innovative"little giant" enterprise founded by Dr. XieJiangbing. The Group's headquarter is in theZhongguancun Science Park in Beijing, withholding companies established in Shanghai,Suzhou, Chengdu, Lianyungang, Yantai, andHong Kong. After ten years of high-qualityinnovative development, the Company waslisted on the Sci-Tech Innovation Board of theShanghai Stock Exchange in 2020, with thestock name "Eyebright Medical" and stockcode: 688050.The Company's balanced product portfoliospans three major areas of the ophthalmicfield: cataract surgery, myopia management,as well as consumer vision care. Adhering to its?ve proprietary technology platforms, balancedproduct portfolio, the Company has establisheda competitive advantage and entry barriers inChina, striding into a world-leading medicalenterprise on behalf of China's "intelligentmanufacturing" power.
Surgical TreatmentThe Company has developed and produced severaldomestic pioneering and market-leading intraocularlenses, including over 20 models such as aspheric,multifocal, extended depth of focus (EDOF), toric,pre-mounted spherical, and pre-mounted asphericlenses.With core technologies in intraocular lenses andcomplete independent intellectual property rights,Eyebright Medical is currently one of the fewintraocular lens manufacturers in China that hassuccessfully entered overseas markets.The Company has launched China's first asphericphakic intraocular lens products, the Loong Crystal
TM
PR, challenging the long-standing dominance of theICL products in the Chinese and global markets.
Myopia ManagementThe Company is the second manufacturer in Chinato obtain a product registration certificate fororthokeratology lens, and is also the world's firstproducer of full-segment aspheric orthokeratologylenses.The core product for myopia control is the orthokeratologylens, while other myopia management products includedefocus glasses, daily wear rigid contact lenses,defocus soft lenses, and related care products.
Consumer Vision CareConsumer vision care products include transparentcontact lens, colored contact lens, prescriptioneyewear lens, and contact lens care products.Subsidiaries hold multiple registration certificatesfor contact lens, colored contact lens, and siliconehydrogel contact lens. Leveraging its research anddevelopment advantages, the Company is developinghigh-end contact lens that offer greater comfort,enhanced safety, and additional functionalities.
Business Layout
2024 Environmental, Social and Governance Report
Development Strategy
Eyebright Medical is dedicated toproviding cutting-edge ophthalmictechnologies, products, andservices to ophthalmic patients andvision care consumers worldwide.The Company will continue toimplement a dual-driven strategy of"Healthcare + Consumer" alongsideinternational development,continually extending its productportfolio to provide comprehensiveeye health solutions worldwide.
Unlock the potential of existing products to solidifymarket leadership
Expand the consumer market andexplore new channels
Inject new momentum for growththrough investments
Strengthen the Company'sleading position in R&D withinthe industry
Enhance overseas presence
Company Culture
VisionMission
MissionCore Values
Core Values
[图片][图片]
CaseCaseCase
In 2024, the Proming ContinuousVision intraocular lens wasincluded in the NationalCentralized ProcurementProgram, enabling nationwideadoption through public hospitalnetworks, thereby meeting thehigh-end demands of domesticconsumers and accelerating theprocess of domestic substitution.
In 2024, Tianyan Medicineand Fujian Unicon achievedsubstantial capacity ramp-up,with the contact lens businessturning pro?table. The Companyembraces new business models,we have established a strategicpartnership with Meituan MedicalHealth and launched the first24 - hour smart contact lensstore in Beijing, setting a newbenchmark for retail innovationin vision care.
In 2024, Eyebright Medicalestablished a regional base inthe Hong Kong Science Park,marking a critical milestone inthe Company‘s global expansionstrategy. The Companyalso actively participatedin international ophthalmicacademic events such as APAO,ESCRS, and the Hong KongScience Park InternationalRegistration Symposium.
ILLUMINATE YOUR WORLD
Innovative and EnterprisingHonestyOpenness and HarmoniousSharing Success
Provide World-classOphthalmic Technologies,Products and Services
2024 Environmental, Social and Governance Report
1011
Development History
2010-20142015-2019Early Technology Accumulation
Expanding Product Portfolio and RapidCommercialization
2020-2025
Initiation of Public Market Listing and Expansion of Operations
2010Company Founded
2014Launch our ?rst Proming AsphericIOL (A1-UV), the First Domestically-Manufactured IOL with IndependentIntellectual Property Rights
2016
NMPA Approval Granted for our Toric IOL2019iBright RGP Contact Lens has receivedNMPA approvalDomestic Users are Covered by Over 2,000Ophthalmology Hospitals
2020Listed on the Shanghai StockExchange's STAR Market2021Completing the acquisition of TianyanMedicine, the Company enter into theSoft Contact Lens Market2022Yantai Production facilities has operatedProming Continuous Vision ReceivedNMPA Approval
2023Controlling interest in Fujian Unicon Optical Co., Ltd.Established Eyebright Hong Kong advance InternationalizationStrategy
2024
Beijing Medical Device R&D Center and Production BaseInauguratedBeijing Future Science City Marketing Center in OperationStrategic Cooperation with Meituan Medicine to Launch 24-hour Smart Stores for Contact Lens2025China's ?rst aspheric phakic intraocular lens product, theLoong Crystal
TMPR Phakic Intraocular Lens has received NMPAApprovalEstablished Eyebright Switzerland to deepen internationalmarket presence
2024 Environmental, Social and Governance Report
12131213
北京企业联合会 北京市企业家协会二〇二四年十二月爱博诺德（北京）医疗科技股份有限公司
第93名
北京企业联合会 北京市企业家协会二〇二四年十二月爱博诺德（北京）医疗科技股份有限公司
第82名北京企业联合会 北京市企业家协会
二〇二四年十二月爱博诺德（北京）医疗科技股份有限公司
第43名
Beijing HeadquarterAwards and Recognitions
Management Team
Holding Subsidiaries
Shandong Specialized and Innovative Small and
Medium-sized Enterprises
Model Employee Home in Penglai District
Jiangsu Specialized and Innovative Small and
Medium-sized Enterprises
Jiangsu Provincial-level Intelligent Manufacturing
WorkshopJiangsu Innovative Small and Medium-sized
Enterprises
Jiangsu Star Cloud EnterprisesJiangsu Suzhou Engineering Research Center
Excellent Management Award of the Jiangsu ProvinceLianyungang CityGanyu District Quality Award
Fujian Province "Gazelle" Innovative Enterprises in
the Core Digital Economy IndustryFifth Batch of Leading Industrial Teams in Fujian
Province
Fujian Province Specialized and Innovative Small and
Medium-sized Enterprises
Fujian Province Postdoctoral Innovation Practice BaseFujian Province Innovative Small and Medium-sized
Enterprises
Third Prize for Excellent Innovative Products fromIndustrial Enterprises in Fuzhou, Fujian Province
Pioneer of the STAR Market2024 Gold Medal CFO Award
Capital Labor MedalOutstanding Secretary of the Board Award at the 15th Tianma AwardsTop 30 Value Companies on the STAR
MarketShanghai Stock Exchange Golden Quality- Corporate Governance AwardMachinery Industry Science and
Technology AwardTop 100 Specialized and InnovativeEnterprises in Beijing 2024Top 100 Manufacturing Enterprises in
Beijing 2024Top 100 High-Precision and High-EndEnterprises in Beijing 2024New Star Unit in Information Work 20247th China Excellence IR Best Disclosure
AwardSecurities Star ESG New Benchmark
Enterprise AwardExcellent Practice Case for CulturalConstruction of Listed Companies 2024Excellent Practice Case for Board ofDirectors of Listed Companies 2024Excellent Practice Case for Board Oce of
Listed Companies 2024
Excellent Practice Case for SustainableDevelopment of Listed Companies 2024TOP 500 New Economy Enterprises 2024
Excellent Practice Case for 2023 AnnualReport Performance Presentation of
Listed Companies
2024 Environmental, Social and Governance Report
1415
Sustainability Management
Eyebright Medical continues to drive innovationto advance global ophthalmic health, whilemaintaining steadfast dedication to theharmonious integration of social responsibilityand corporate growth. As a responsibleCorporate Citizen, we tirelessly work togradually fulfill our mission. By seizing theopportunities presented by the new era oftransformation, we continuously focus onthe environment, and social responsibility.We actively respond to the concerns andexpectations of both internal and externalstakeholders.
United Nations Sustainable
Development Goals
ESG Management System
To enhance ESG management practices, Eyebright Medical has established a multi-tiered management system.The management team oversees strategic decisions, integrating ESG principles throughout all businessprocesses. An ESG task force develops action plans to advance key environmental, social, and corporategovernance initiatives. This structured approach ensures the seamless integration of ESG goals into our businesspractices, fostering e?ective implementation across the organization.
ESG Strategic Planning
Product Sustainability
Operational SustainabilityWe continuously optimize thegovernance framework, identify andassess key risks, and develop measuresto establish a standardized, transparent,and fair governance mechanism thatensures sustainable development
Social Sustainability
StakeholdersExpectations and DemandsResponse Methods/Communication Channels
Stakeholder Communication
Shareholders
Regulated CorporateGovernance SustainedValue Creation InformationDisclosure
Enhance corporate governance and investor relationsinvolves, and use online platforms to promptlyaddress investor inquiries. Deliver consistentpro?tability and timely ?nancial disclosures
Customers
Product Safety and QualityDiverse O?erings Privacyand Information SecurityResponsible Marketing
Provide high-quality products and services.Implement robust information security measures toensure the protection of customer privacy
Employees
Basic Rights ProtectionTraining and PromotionCompensation and Bene?tsHealth and SafetyWork-Life Balance
Sign labor contracts and remits social insurancein compliance with local law. Maintain competitivesalary levels, provide multidimensional trainings foremployees. Maintain rigorous occupational health andsafety standardEnvironmental
Environmental ProtectionReduce Pollution EmissionsEnhance Energy Eciency
Establish mid- to long-term environmentalmanagement goals, implement energy-saving andemission-reduction initiatives, and promotes greenoce practices
Partners
Win-Win CooperationSustainable Supply ChainContribute to IndustryDevelopment
Establish standardized procurement systems andenhances supply chain management, maintain a fairand orderly competitive environment. Build academicexchange platforms and conducts industry training,initiates industry-university-research cooperationprojectsGovernmentand RegulatoryAuthorities
Operate in accordance withthe lawComply with business ethics
Ful?lls tax obligations, enhance anti-bribery and anti-corruption measures
Materiality Assessment
The ESG report aims to comprehensively disclose key issues in the areas of environment, social responsibility,and corporate governance, thereby enabling stakeholders to accurately assess the Company's ESG performance.In 2024, Eyebright Medical conducted a comprehensive materiality assessment to identify priority ESG topics,integrating past practices, industry development trends, and international ESG standards.
We prioritize employee rights by fosteringa diverse, inclusive, and equitable workenvironment. We will remain activelyinvolved in social welfare activities,leveraging our expertise to contributegreater value to society.
We firmly believe that research andinnovation are crucial drivers ofsustainable development. We arecommitted to ongoing investment inR&D to develop cutting-edge ophthalmictechnologies and products.
2024 Environmental, Social and Governance Report
1617
EnvironmentalEyebright Medical integrates the concept of green development into its corporate strategy and daily operations.By enhancing environmental awareness, efficiently utilizing resources, reducing waste, and implementing greenoperational practices, the Company actively assumes environmental responsibilities and promotes harmoniouscoexistence between humanity and nature.
2024 Environmental, Social and Governance Report
181819
2024 Environmental, Social and Governance Report
Eyebright Medical strictly fulfills its environmentalprotection. The Company comprehensively strengthens itsenvironmental risk management mechanisms, adopts eco-friendly measures, explores new energy infrastructure, andpromotes green sustainable development. Its e?orts aim toachieve a win-win situation in environmental protection.
Environmental Management
Eyebright Medical prioritizes environmental protection as a coremission, adhering to the Environmental Protection Law of thePeople's Republic of China. The Company optimizes processes andupgrades facilities to implement stringent standards, significantlyimproving environmental governance. In March 2025, EyebrightMedical achieved ISO 14001 certi?cation.To further its commitment to green development, the Companyestablished an Environmental Health and Safety (EHS) department.This initiative aligns with national goals for carbon peak andneutrality by 2030.
Environmental Management System
The Company strengthens its environmentalrisk management capabilities in accordance withregulations in China. It has established internalprocedures for emergency management and hazardidenti?cation, implementing e?ective measures suchas regular inspections, environmental monitoring,and emergency response to strengthen risk controland reduce the environmental impact of incidents.A comprehensive annual environmental managementobjective system is supported by a robustgovernance structure where the board providesstrategic oversight and the EHS departmentcoordinates efforts cross-functional efforts. Regulardrills for environmental emergencies have beenconducted, enhancing the emergency responsecapabilities of responsible personnel from processmanagement to incident handling.
Environmental RiskManagement
During the Reporting PeriodNo incidents of environmentalviolationsNo media exposure incidents relatedto environmental issues
Conduct regular inspections of environmental facilities to checkoperational and equipment wear statusTimely maintenance is carried out to ensure the safe and e?ectiveoperation of all environmental facilitiesEnvironmental FacilityInspections
Regularly perform environmental monitoring to e?ectively trackpollutant emissionsActively engage in environmental impact assessments, supervisoryaudits, and clean production auditsEnvironmentalMonitoring
Establish a comprehensive emergency management system forenvironmental incidentsDevelop and re?ne the "Emergency Response Plan for EnvironmentalIncidents" and other related documentsClearly outlining emergency response processes and handling standardsEmergencyManagement
2024 Environmental, Social and Governance Report
2021
Pollution Prevention
Waste Water Management
Eyebright Medical is rigorously adhere to the Environmental Protection Law of the People's Republicof China. Our pollution prevention strategies are embedded in all stages of research, production,and operations.By emphasizing proactive measures over remediation, we effectively reducepollutant emissions through installing environmental protection equipment, process enhancements,and robust management practices, thereby minimizing our impact on the environment.
The Company complies with national and local standards by implementing e?ective emergency managementmeasures for water pollution. Industrial and domestic wastewater generated during daily operations isprocessed through the Company’s treatment systems and safely discharged into municipal sewer networks uponmeeting relevant discharge standards.
Eyebright Yantai Wastewater Treatment Process Renovation
The Company complies with local environmentalassessment requirements by engaging qualifiedthird-party organizations to monitor pollution sourcesincluding wastewater, exhaust emissions, and noisein accordance with local environmental assessmentrequirements. During the Reporting Period, fourmonitoring tests were conducted and all results werewithin regulatory discharge limits.
Case
Through the renovation of wastewater treatment processes, the wastewater treatmentplant achieved a"one increase, one decrease", enhancing wastewater treatmentcapacity while reducing costs.
MBR
Eyebright Medical prioritizes environmental responsibility by strictly adhering to the Air Pollution Prevention andother relevant regulations. The Company adopts a scienti?c and rigorous approach to air pollution preventionand emissions control.The Company implements a variety of e?ective puri?cation techniques, including activated carbon adsorption,vacuum cleaning, and high-efficiency grease purifiers. During the reporting period, the Company engagedprofessional agencies to conduct regular monitoring of emissions, and results from non-organized tests werecon?rmed compliance with standards.
Air Quality Management
During the Reporting Period
No media exposure incidents relatedto environmental issues for theCompany or its subsidiaries
WastewaterCollection Tank
Clean-WaterReservoir
PH Regulation
FlocculationReactionA2O Process
2024 Environmental, Social and Governance Report
2223
The Company headquarters generated
9.646
tons of recyclable waste
The Company strictly complies with the Solid Waste Pollution Prevention and Control Law and the Medical WasteManagement Regulations of the People's Republic of China. The Company has established relevant managementsystems encompassing the entire process of solid waste generation, collection, storage, transportation,utilization, and disposal, ensuring e?ective environmental pollution prevention and control.The Company's solid waste includes general and hazardous waste. General solid waste consists of materialspreparation waste, packaging waste, and household garbage, which are entrusted to qualified third-partyorganizations for transportation, recycling, and disposal. Hazardous waste primarily includes experimental wasteliquids, used reagent bottles, and spent activated carbon. The Company implements strict controls on hazardouswaste, storing it separately in designated collection devices based on its category and nature. Quali?ed third-
Waste Management
The Company has equipped high-eciency fume hood systems to enhance laboratorysafety and maintained environmental quality. These systems promptly and e?ectivelyexpel harmful substances generated during experiments, effectively controlling thespread of these substances at the source. This initiative safeguards the health andsafety of laboratory personnel and ensures the stable operation of equipment andinstruments.
Fume Hood System
Empty Tube Recycling ProgramCase
Case
Starting in 2024, the Company Skin brand "HiGenie" under the Company launched a " EmptyTube Recycling" program. This initiative encourages consumers to participate in sustainableconsumption through the distribution of no-threshold coupons and the exchange of emptytubes for genuine products. Collected tubes will be sent to a third-party recycling facilityfor cleaning and shredding, where they are processed into recycled pellets for use inmanufacturing processes.
party organizations are engaged for the harmlesstreatment of hazardous waste to ensure properdisposal.The Company conducts regular training sessions forhazardous waste management that cover applicablelaws, regulations, and management systems,ensuring e?ective management at every stage.
During the Reporting Period
2024 Environmental, Social and Governance Report
2425
Noise Management
The Company strictly adheres to national and local standards, such as the Industrial Enterprise BoundaryEnvironmental Noise Emission Standards, ensuring that boundary noise complies with environmental emissionstandards. This helps reduce and prevent noise pollution and its harmful effects on the environment andhuman health. Additionally, the Company thoughtfully designs the layout of its facilities and scienti?cally plansproduction processes to control noise generation and propagation at the source.
Noise Reduction Measures
Implement fundamental vibration dampingmeasures to minimize noise during equipmentoperationUtilize specialized mu?ers to further reducethe noise intensity of equipment emissions,ensuring quieter operation
Implement fundamental vibration dampingmeasures to reduce vibrations duringoperationInstall soundproof walls and doors to blocknoise transmission paths, e?ectively isolatingsound from the surrounding environment
Install soundproof enclosures to contain thenoise generated by equipment, preventing itsspreadUtilized advanced soundproofing materialsand scientifically designed noise reductionprocesses on crystal freezing fixtures,achieving an overall noise reduction ofapproximately 10 decibels, which e?ectivelyimproves the working environment foroperators
Fans, Air Compressors, and Similar Equipment
Various Fluid Transfer Equipment
Production Equipment
Acoustic Enclosure
The installation of an acoustic containmentsystem has successfully reducedoperational noise within the productionprocess, signi?cantly improving overallenvironmental conditions.
Case
Resource Management
Eyebright Medical continuously strengthens its regular resource usage management, focusingon reducing, reusing, and recycling resource consumption at the detail level. The Companycomprehensively improves resource utilization eciency, fully leverages its innovative advantages,and promotes the implementation of resource recycling and green alternatives.
Eyebright Medical places a high emphasis on theimpact of water resource consumption on theenvironment, and is committed to the protection,conservation, and rational use of water resources.The Company regularly monitors water usage,promptly analyzes any anomalies, and immediatelyformulates and implements targeted water-savingmeasures. In 2024, the Company was selected intothe Beijing Water-Saving Enterprise Directory.
Water Resources Management
Comprehensive Upgradeof Puri?ed Water Equipment
Water-Saving Measures
Case
Implement advanced membrane separationtechnology and intelligent control systemsto precisely adjust operational parameters,e?ectively minimizing water resource waste
Optimizing the opening and closing times ofmain valves to control water ?ow e?ectivelyLimiting water ?ow to reduce consumptionDisplaying water-saving signage,encouraging the practice of turning o?faucets when not in useConducting routine maintenance of watersupply and storage facilities
Rainwater Retention PitsCase
Use peak shaving and flood controlmethods to alleviate drainage pressure,ensuring the stable operation of thedrainage systemPrevent ?ooding within the park to ensurethe safety of production equipment androad accessibilitySettle oil, heavy metals, and otherpollutants from rainwater to protect theaquatic ecosystemUtilize rainwater resources for landscapingirrigation, reducing the Company's watercosts
2024 Environmental, Social and Governance Report
2627
Green ProductionDuring production processes, Eyebright Medical adopts advanced environmentally friendly technologies andequipment to e?ectively reduce energy consumption and waste emissions. The Company continuously optimizesproduction work?ows to enhance resource eciency, minimize waste generation, ensuring full compliance withenvironmental standards.
Smart Factory
Tianyan Medicine—a subsidiary ofEyebright Medical, leverages newindustrialization as a driving force tocontinuously enhance the intelligenceof smart factories, smart workshops,and automated production lines. Thiscommitment has earned it the "SmartManufacturing Workshop"honorfrom Jiangsu Province for its"Intelligent Transformation andDigital Networking" ,as well as the"Excellence in Quality ManagementAward" from Ganyu District.
CaseAutomated Packaging Production Line
The production line was upgraded frommanual to semi-automated packaging, andvision inspection system was introducedto improve error detection accuracy andeciency.
Automated Data Recording
Scanning and Inventory System
Kanban Management
Energy-Saving MeasuresThe puri?cation HVAC system in the production area utilizes variable frequency technology to optimizeenergy eciency through intelligent cycling control of indoor/outdoor units.Outdoor lighting systems use programmable timer switches to deactivate at predetermined intervals,while indoor switches integrate visual/auditory shutdown alerts. Centralized monitoring teams conductinspections before leaving to ensure all lights are turned o?, reducing unnecessary energy consumption.The lighting system in the underground parking area has been upgraded to save energy by turning o?non-essential lighting ?xtures, ensuring necessary illumination while maximizing energy savings. Thisinitiative is expected to save nearly 10,000 kWh annually.Certain production areas have installed photovoltaic systems to harness solar energy, a clean energysource, reducing reliance on non-renewable energy.The Company explores technological upgrades for energy conservation and emission reduction,including waste heat recovery for air compressors. This captures and reuses heat from cooling water,enhancing waste heat utilization and improving overall energy eciency.
Energy Management
The Company actively promotesthe systematic construction of itsenergy management system and hasestablished regulations such as the"Electricity and Energy ConservationManagement Guidelines" to drivediverse energy-saving initiatives andcontinually explores opportunitiesfor energy reduction. The Companyeffectively reduces energy usage,enhances energy efficiency, andfosters a sustainable productionand operational model focused onenergy conservation and efficiencyenhancement. In February 2025, theCompany achieved ISO 50001 energymanagement system certi?cation.
Data is automatically recorded in testingfor quick query and analysis. saving paperresources and improves testing efficiency by50%.
Products quickly generate a UDI thatincludes key attributes and traceability data,streamlining inventory operations for bettermanagement.
A Kanban management system allows tomonitor real-time progress and adjust taskpriorities .
2024 Environmental, Social and Governance Report
2829
Green Oce Practices
The Company actively promotes green oce practicesand eco-friendly commuting by implementing digitaland paperless operations, effectively reducingresource waste and energy consumption. It enhancesenergy-saving and environmental awareness in oceareas, fostering a participatory and collaborativeatmosphere. Through these practices, the Companydemonstrates its commitment to low-carbonand environmentally friendly principles in dailyoperations.
Climate Action
Addressing climate change has become a global trend. Eyebright Medical is committed tosustainable development principles. The Company continuously monitors climate change trendsand prioritizes climate action within its growth strategy. Actively identifying and systematicallyevaluating climate-related risks and opportunities, we formulated tailored strategies to mitigaterisks to business continuity and stability.
The Company actively embraces the concept of low-carbon living, advocating for green production and ocepractices. It conducts extensive training on energy conservation and low-carbon initiatives, continuouslyenhancing employees' awareness of the importance of climate change. We encourage everyone to take practicalactions, collectively contributing to environmental protection.
Utilize renewable materialsImplement resource-ecient designAdopt more ecient transportation modesOptimize production and distribution
processes
Create low-carbon productsImplement low-carbon green
manufacturing processesEstablish diversi?ed productionarrangements across multiple
locations
Develop energy-saving andemission reduction plansUse clean energy sources
Leverage government incentives for low-carbon initiativeEngage in partnerships between academia and industry
Empower supply chains for sustainability
Risk TypePotential Impact of RiskPhysical Risks
Acute
Extreme weather events (?oods and typhoons) threaten supplychain stability, making it dicult to ensure consistent productsupplyChronic
Long-term climate shifts can impair employee health andproductivity, a?ecting R&D and manufacturing eciency
Transition Risks
Policy andRegulation
Implementation of carbon emission control policies may increaserequirements for climate response and disclosureMarket
Shift in market preferences towards low-carbon products mayresult in a decline in sales of medical equipmentTechnology
Lagging energy technologies could lead to increased productioncostsReputation
Decreased stakeholder interest in non-environmentally friendlyproducts, potentially harming brand reputation
ResourceEciency
Energy Sources
Products andServices
MarketResilience
Climate Risks
Opportunities and initiative brought by climate changeOce SuppliesManagementInitiatives
Implementing a paperless approach by using electronic media for drafting, editing,circulating, and approving documentsEstablishing a system for planning and controlling printed materials, requiring advanceapplications and approvals to prevent wastePracticing responsible procurement of oce supplies, promoting reuse, and conservingoce materials
ElectricityConservationManagementInitiatives
Promoting the use of energy-saving light ?xtures and encouraging employees to switcho? indoor lighting when not needed, especially after hours or during extended absencesEnsuring that computers, printers, and other oce devices enter energy-saving modeduring intermittent use, and turning them o? and unplugging when not in useAdjusting air conditioning temperatures to avoid excessively high or low settings, therebyreducing overall energy consumption
New Energy Vehicle
Initiatives
Converting Company shuttles and ocial vehicles to new energy models.Encouraging employees to use public transport by providing support through transitcards, collectively fostering low-carbon commuting practices
2024 Environmental, Social and Governance Report
3031
Social
2024 Environmental, Social and Governance Report
Eyebright Medical actively fulfills its corporate socialresponsibility, emphasizing scientific research,innovation, and academic exchanges while ensuringthe highest product quality. The Company prioritizesemployee growth through providing robust careerdevelopment platforms, engages in social welfareactivities, and leverages its resources to contributeto public health improvement.
32333233
Innovation Empowerment
Eyebright Medical views innovation as the cornerstone of high-quality development. In the ophthalmic eld,we strategically advance research initiatives, strengthen our R&D team, and foster a comprehensive industry-academia-research platform. We continuously build our cutting-edge technological capabilities and researchexcellence while establishing a robust support system to safeguard our scientic innovations.
Eyebright Medical refines its R&D managementsystem through optimizing R&D regulations andstrengthening innovation capabilities. A projectleader system ensures end-to-end oversight ofproduct development—from market research to post-market feedback, enhancing researcher expertise,coordination efficiency, and product developmentsuccess rates.
Scientic Research Framework
To enhance project R&D efficiency and quality, theCompany focuses on building a high-quality R&Dteam. We implement a regular training programthat covers covering advanced technical knowledge,standardized procedures, and regulatory compliance,which boosts the technical innovation and operationalstandards of our R&D personnel, ensuring effectiveproject execution and quality control.
"Intelligence -Driven Innovation: Advancing Together in R&D"
2024 Annual Eyebright Medical R&D Work Conference
"Innovation Sets Sail: Collaborating for Success"Patent Training Session
Type Testing-Clinical TrialsProductRegistration
Market Research
Clinical Trials
Market Launch-
PostProductRegistration
PreliminaryExperiments
R&D ProjectInitiation
Market ClinicalResearch
Company R&D Workflow
Recently Introduced Products
Ultra-thin, double-concave designIdeal performance in the eye gap
received NMPA approval in Jan,2025THIN
STABLE
CUSTOMIZED
WIDE
6.0mm optical region with zero
spherical aberrationHigh-quality visual performance
10 models for precise matchingPersonalized options available
Stable arch height with
excellent supportLong-term intraocular stability
Technological innovation is criticalto maintaining the Company's corecompetitiveness. Eyebright Medical focuseson cutting-edge technology, consistentlyinvesting a significant portion of resourcesinto R&D to enhance innovation andefciency, supporting the achievement of theCompany's strategic goals.
R&D Investment
20222023
Million (RMB)
2024
82.06
132.30
YOY
61.23%
YOY
20.80%
159.82
as of Dec 31, 2024R&D Investment Over the Past Three Years
3435
Registration certicates for multiple preloaded intraocular lenses
Renewal of registration certicates for various preloaded intraocular lensesRegistration certicates for multiple preloaded intraocular lensesRegistration certicates for multiple preloaded intraocular lensesRegistration certicates for various soft hydrophilic contact lenses GMP Certication Inclusion in the Hospital Authority’s List of Licensed Suppliers
ThailandMalaysiaBangladeshPakistanIndonesiaBrazilHong Kong
iBright Bionic Compound-Eye
Defocus Spectacle Lens
Ophthalmic Viscoelastic Agent
7 types of Soft Hydrophilic Contact LensMulti-Model Preloaded AsphericIntraocular Lens System / Preloaded
Intraocular Lens System
AINNOVI?3D VisualizationSystem
Rinsing Solution for Rigid GasPermeable Contact Lens
Hydrogen Peroxide Multi-Purpose Solution
iBright High-order Aspheric SoftHydrophilic Contact Lenses
Handheld Thermal Pulsation Devicefor Meibomian Gland Dysfunction
International
China mainland
Eyebright Medical rigorously implements China's innovation-driven development and intellectual property powerstrategies by adhering to the Patent Law of the People's Republic of China and Copyright Law of the PRC. TheCompany has established a robust copyright management system through institutionalizing policy documentssuch as the Intellectual Property Management Manual, Patent Administration Protocols, Trademark RegistrationGovernance Procedures, and Copyright Compliance Guidelines. It conducts systematic patent evaluation,disclosure, and commercialization initiatives to enhance technology transfer efficiency, thereby elevating itsmanagement capabilities to global standards in alignment with national innovation priorities.
The Company strictly follows welfare and ethical review requirements for animal experiments. Pre-experimentassessments evaluate necessity, scientific value, and potential harm.We prohibit any meaningless abuse orunnecessary killing of animals, halting experiments that lack scientic signicance or are non-essential."3Rs" principle of Reduce, Replace,and Rene guilds the implementationof animal experiments. We carefullyplan and design experiments tominimize the use of animals, activelyseek alternative methods to reducedependency, and continuouslyoptimize procedures for morehumane practices, minimizing animalsuffering.We ensure that experimental animalsenjoy basic rights and respect theirability to express emotions. Ourcommitment to treating animalswith kindness and respecting theirlives is integral to our entire animalexperimentation process.
Intellectual Property Protection
Experimental Ethics
International patents covering Europe, USA, Japan, South Korea, and Singapore
Patents AppliedTotal Patents Applied
Patents GrantedTotal Patents Authorized and Valid
417256
3637
Eyebright Medical fosters domestic and international academic exchanges, creating a global platform thatintegrates medical research with clinical practice. We participate in the Formulation of Sector Standards,collaborate with universities to train ophthalmic talent, and strengthen the link between research and education,contributing to innovation in ophthalmic healthcare.
Eyebright Medical considers communication andcollaboration essential for innovation. We activelyengage in domestic and international academicexchanges, organizing forums and seminars toconnect with ophthalmic experts and address keychallenges in the eld.In 2024, Eyebright Medical participated in majornational conferences, including the NationalOphthalmology and Cataract Conferences, andinternational events such as APAO and ESCRS. Wealso actively joined multiple provincial and municipalacademic conferences across China. Our innovativetechnologies garnered global recognition at variousregional meetings.
During the Reporting Period, Conference Highlights
International Exhibitions
National Conferences
Regional Meetings
Online Participants
2,783
Viewing Time
minutes141,477
Self-hosted Meetings
Total Professional Viewers29,088
Collaborative Industry Advancement
Academic Exchange
Experts engaged in multidimensional discussionson myopia prevention, frame glasses, andthe real-world data of iBright lenses, praisingEyebright Medical’s comprehensive approach toprecise myopia management.
iBright Defocus Lens Data
Release Event
Focusing on Orthokeratology lens, andencompassing defocus RGP, rigid lens caresystems, defocus glasses and defocus soft lenses,we invited regional KOLs and young optometriststo share clinical experiences, enhancing themarket influence of iBright and promoting ourentire optical product line while providing alearning platform for practitioners to elevateindustry standards.
High-Order Aspheric Clinical Sharingand Soft Lens Release
Combining in-person and online formats,clinical experts provided fitting demonstrations,discussing product features, fitting techniques,and patient assessments, while addressingquestions to keep optometrists informed aboutnew technologies and products.
Elite Optical Fitting Studio
A seminar brought together experts fromindustry, clinical, and research sectors to focuson clinical topics and global advancements inophthalmology. This enhanced the visibility of theiBright brand, established its premium image,and cultivated a high-end user base, expandingmarket share.
Accurate Refraction andVision Improvement
3839
We believe high-quality corporate standards are the foundation for safeguarding innovation, technical strength,production capacity, and social responsibility. They also serve as a bridge for communication and trust betweenthe Company and customers, partners, industry organizations, and the public, and as a key tool to enhancecorporate competitiveness. Eyebright Medical has been actively engaging in and advancing the standardizationof ophthalmic medical devices to promote quality development of the eye health industry.During the Reporting Period, the Company participated in revising standards, and contributed to industryreports
Standard/Report NameParticipation
Standard Establishment
GB 11417.2-20XX Ophthalmic Optics - Contact Lens, Part 2: Rigid Contact LensGB 11417.2-20XX Ophthalmic Optics - Contact Lens, Part 3: Soft Contact LensYY T0942-20XX Ophthalmic Optical Intraocular Lens Implant SystemsPost-Market Surveillance for Medical Device ManufacturersOrthokeratology Lens Fitting GuidelinesSoft Contact Lens Fitting Service StandardsApplication Guidelines for Myopia Control Related Frame GlassesSouthern Institute of the National Medical Products Administration: "Report onHigh-Quality Development of the Chinese Ophthalmic Medical Device Industry"National Vocational Education: Textbook on Optical Technology for Contact LensFitting (Third Edition)
In revision and validationIn revision and validationIn revision and validationIn revision and validationParticipation in DraftingParticipation in DraftingParticipation in DraftingParticipation in DraftingParticipation in Drafting
Now in its fourth year, the event evolved into "SHOWYour Sherlock Eye - A Journey into Orthokeratology,"gaining significant attention from industry expertsand optometrists, becoming a highly impactfulacademic activity.
SHOW Your Sherlock Eye
Continuously streamed online, this camp helps physicianscomprehensively learn about multifocal lens, coveringeverything from optical theory to surgical planning and clinicalpractice. The content is structured in a progressive manner—starting from foundational concepts, advancing throughprocedural planning, and culminating in real-world clinicalapplications—to support physicians’ professional advancement.
Multifocal Intraocular Lens Training Camp
Eyebright Medical's "iBright Spark Program" strengthens R&D and talent development through university-industry partnerships. By adopting innovative models like resource sharing, joint training, and curriculum co-creation, the program jointly builds practical training bases and integrated education-industry platforms withuniversities. This initiative delivers market-aligned professionals with practical competencies to the ophthalmicoptics sector, providing robust talent support for the industry's sustainable prosperity and development.
School-Enterprise CooperationiBright Spark Program
Established partnerships withuniversities 5Donated: over RMB 1.2 millionin materialsBeneted: more than 1,400students
Collaborated with a total of 15 universitiesExtended reach to 12 provinces and municipalitiesDonated over RMB 4.5 million in materialsProvided 500 hours of trainingEmpowered over 2,500 studentsBeneted more than 10,000 vision care professionals
In a session combining theoryand clinical practice, many onlinephysicians learned personalizedstrategies for myopia prevention andthe precise tting techniques of iBrightlenses, enhancing their clinical skills.
Effective Prevention and ComfortableBalance
Since 2022During the Reporting Period
4041
Eyebright Medical collaborates with renowned ophthalmic hospitalsand industry associations to establish three training bases in ChinaEye Valley, Tianjin Eye Hospital Optometry Center, and its Beijingheadquarter. These centers offer multi-dimensional and tiered learningplatforms designed for optometry professionals at different stages.The training program covered cutting-edge theoretical knowledgein standardized fitting protocols and myopia prevention and control,signicantly enhancing the expertise and practical skills of grassrootsoptometry practitioners in the eld of refractive error management.
Training and Talent Cultivation
China Eye ValleyTianjin Eye Hospital Optometric CenterEyebright Medical Beijing headquarter
Three Major Training Bases
Opened in 2021, the trainingprogram have trained over 550professionals from more than 370hospitals and vision centers across30 provinces. This systematicapproach has enhanced participants'skills and competencies, supportingtalent development in the eye careindustry.
During the Reporting Period
Conducted 5 trainingsessions
A calculated total 118hours training time
Engaged over 200participants
IBRIGHT ELITE Youth Paper AwardFounded in 2021, the IBRIGHT ELITE Youth Paper Award, in collaboration with the InternationalConference on Visual Health Innovation, encourages young ophthalmologists, vision carepractitioners, and students to explore the elds of ophthalmology and visual health. It promotesacademic exchange and innovation, fostering the growth of future leaders in the eye careindustry.vDuring the Reporting PeriodPremier Paper Award (Best Winner)recipients
Outstanding Paper Awardrecipients
Excellent Poster Awardrecipients
Popular Paper Awardrecipients
Excellence Paper Awardrecipients
Supported: 71 YoungScholarsTotal Young ScholarsFunded: 234Total Funding Amount:
Over RMB 350,000
4243
Accessibility of Medical Services
Using the ISO 9001 framework, we comply withregulations such as GB/T42061 and ISO 13485,integrating quality risk management into ourprocesses,and comprehensively ensuring the robustoperation of the Company's quality managementsystem.Quality Management System
Eyebright Medical regards product quality as the lifeline to its operations. We uphold strict safety standards,build a sustainable supply chain, and optimize customer service to ensure every step—from raw materialprocurement to delivery—meets the highest industry standards.
Eyebright Medical strengthens its quality and safetymanagement systems through robust organizationalstructures, policy development, regulations, andtraining, thereby ensuring effective operation thatsafeguards patient health.
The Company has successfully undergone fournational product inspections in 2017, 2020, 2022,and 2024, with all results confirming that ourproducts meet technical requirements, demonstratingthe effectiveness of our quality management system.
During the Reporting Periodsuccessful external inspections all passedon the rst attemptmajor product quality incidents have beenreported
NO
Quality Management
Product Responsibility
GB/T42061KGMPISO 13485EU MDRCE CerticateMedical Device License
GMPISO 9001
2017
20202022
2024
%
Pass
Rate
in
National
Supervision
Eyebright Medical is committed to creating value by providing high-quality, convenient eye health services. Weleverage technology, including articial intelligence, to improve the quality and accessibility of ophthalmic care,ensuring that grassroots communities enjoy fair, fast and convenient eye health services.
In 2024, we partnered with Meituan Healthto launch China's first 24-hour smartcontact lens store—Meiyue Tong TOPPOPSmart Store—in Beijing. Citizens can placeorders anytime via the Meituan platform.Once an order is received, a humanoid AIrobot automatically sorts and retrievesthe product, prints an electronic receipt,seals the items, and deposits them intoa self-service pickup cabinet. A deliveryrider then collects the package using apickup code. The 24 - hour smart storenot only provides citizens with faster,more precise 'zero - distance' purchasingexperiences for contact lenses, but alsosignificantly enhances store productivityand operational efciency.
Pioneering 24-Hour Smart Contact Lens Store in ChinaCase
4445
CNAS testing center
We prioritize the enhancement of quality awarenessacross all employees and quality competency amongprofessionals. The Company organizes diversetraining sessions tailored to job roles, coveringtopics such as quality knowledge, specialized skills,procedures, relevant laws, industry standards,and professional ethics. Through comprehensivetraining, all personnel shall thoroughly comprehendthe criticality of quality and safety, acquire essentialknowledge and skills, and effectively implement allquality safety regulations, thereby establishing arobust foundation for the Company's sustainabledevelopment and quality enhancement.
Quality and Safety Training
During the Reporting Periodthe Company conducted nearly quality andsafety training sessions.
The Company has established a "Risk Management ControlProcedure" to identify, analyze, evaluate, and controlrisks related to product safety. These risks are regularlyreassessed and improved, standardizing and monitoringall aspects of product development, production, facilitymanagement, and material management to ensure stableand reliable product quality.
Our testing center has receivedlaboratory accreditation from theChina National Accreditation Servicefor Conformity Assessment (CNAS),making it the first enterprise-based lab in China for intraocularlens testing. The center is equippedwith advanced testing equipment,continuously ensuring the quality andsafety of our products.
Quality Safety Management and Control
Non-Conforming Product Control ProcedureAdverse Event Control TeamInformed Service SystemProduct Recall Control Procedure
Service capability and quality are key strengths for Eyebright Medical, reecting our brand image. We prioritizecustomer needs through responsible marketing and a comprehensive service system. We continuously reneservice process management and proactively gather customer feedback to deliver superior user experiences.
We have established a standardized surveymechanism, and conduct customer satisfactionsurveys every six months.Through thorough datacollection and analysis,potential issues in productsand services are proactively identified.Targetedimprovement measures are implemented tocontinuously enhance product quality and optimizeservice experience, ensuring timely identication andresolution of potential problems to deliver superiorservices to clients.
Customer Service
Communication Platforms Matrix
400 CustomerService HotlinesOnline Services
Customer ForumsIntelligent Self-Service System
Market Research
CustomerSatisfaction Surveys
9.8/10
Average Satisfaction Score ExceedsIn 2024, the Company surveyed ouragents and partnered hospitals service andproduct satisfaction, covering usability,effectiveness, and delivery processes.Results showed that the averagesatisfaction score exceeded 9.8, indicatinghigh satisfaction with our products.
Customer Satisfaction SurveyCase
During the Reporting Period
Major Customer Complaints OccurredNO
4647
Suppliers are classied, evaluated, and performance-tracked according to relevant
rulesQualied suppliers are assessed and recorded, with a dynamically updatedlist to ensure safe, stable, and efcient procurementEstablished an "On-site Inspection System for Key Suppliers" to
evaluate the production environment, quality management systems,product manufacturing processes, and delivery capabilities of criticalsuppliers
Sustainable Supply Chain
Responsible Procurement
Supplier ManagementAs a responsible STAR Market-listed company, Eyebright Medical sees supplier management as an extensionof our corporate values. We follow three key principles: selecting high-quality suppliers aligned with ourculture, building long-term partnerships for sustainability, and integrating corporate social responsibility andenvironmental protection into our supply chain. This approach ensures exceptional product quality and promotesa healthier, more sustainable medical ecosystem.
Evaluation System
TieredManagement
On-site Inspections
Eyebright Medical values employees, fostering a culture centered on innovation, openness, integrity, andshared success. We respect each individual and aim to create a diverse and inclusive workplace. By providing aplatform for talent expression, we inspire creativity and work together to achieve personal and company goals.
Eyebright Medical upholds equality and inclusiveness in hiring, strictly following the Labor Law of the PRC.We have implemented systems like the "Personnel Recruitment Management System" and the "RetiredReemployment Management System" to ensure a fair hiring process and protect the rights of employees andapplicants.As of the End of the Reporting Period
The Company employs a total of employees
Compliance in Hiring
Employee Development
Employees Rights and Interests
Establishing proceduresPlanning requirementsSigning agreements
Female EmployeesEthnic Minorities
Gender DistributionAge DistributionEthnicity Distribution
Male EmployeesHan Chinese
<3041-5031-40>50
2,294
During the Reporting Period
Returns Due to Incoming Inspection Issues have been ReportedNO
4849
The Company promotes fairness and justice inrecruitment, training, and promotion, treating allemployees equally regardless of region, ethnicity, age,gender, religion, or culture. We prioritize the rightsof female employees by adhering to relevant lawsand providing equal opportunities and professionalgrowth.Eyebright Medical places high priority on protectingthe rights and interests of female employees, strictlycomplying with the Constitution of the PRC, the Lawon the Protection of Women's Rights and Interests,and the Special Regulations on the Labor Protectionof Female Employees. We provide female employeeswith fair and equitable career opportunities andample professional development space. The Companyfosters a supportive professional environment forwomen through its corporate culture and managementframework.We also respond to government initiatives byproviding job opportunities and benefits for peoplewith disabilities, fullling our social responsibility. In2024, we offered positions to 12 disabled individualsat our headquarters.
Equal Workplace
Eyebright Medical regards employees' workenthusiasm and innovative capabilities as the drivingforce for the Company's sustainable high-qualitydevelopment. We have developed a comprehensivecompensation system that aligns with market-based standards, offering incentives like salaries,performance bonuses, and equity options to boostmotivation and loyalty.
Eyebright Medical views employees as keycontributors to the Company's success. We employboth internal selection and external recruitmentto meet business needs while providing careerdevelopment opportunities for our staff, optimizinghuman resource allocation.We champions a high-performance-orientedcorporate culture that prioritizes efficiency whileensuring fairness. Our performance managementsystem is aligned with business goals and cascadesdown to departments and individual employees,linking company performance closely with personalachievements.
In 2024, the Company conducted a talent review tocreate personalized career development plans forcore employees, establishing clear promotion paths.
In 2024, we strictly adhered to relevant laws andboard resolutions to implement stock incentivesfor qualified employees under the "2021 RestrictedStock Incentive Plan," allowing employees to sharein the Company's success and stimulating coretalent's motivation and innovation, and encouragingtheir long-term commitment to the Company’sdevelopment.
Compensation IncentivesCultivation and Development
Promotion Mechanism
Work PlansKey PerformanceIndicators
Work Attitude
During the Reporting Period
During the Reporting Period
of the senior executive teamconsists of female members
Granted incentive shares to 78employees
50%
206,982
FemaleMale
5051
Eyebright Medical considersemployees our most valuableasset, prioritizing theirskill enhancement andcareer development as keycomponents of our HR strategy.We optimize training processesto align with strategic goalsand business needs, creatinga comprehensive system thatincludes leadership, businessempowerment, onboarding, andinternal knowledge sharing.This investment strengthens ourworkforce and helps maintainour competitive edge in adynamic market.
In 2024, Eyebright Medical launched the "Peking University Economic Management TrainingProgram", bringing middle and senior-level executives and partners to learn about internationaltrends, cutting-edge research, and advanced management practices. This initiative broadens theirperspectives, helping them understand industry challenges and opportunities to develop forward-looking strategies and high-performance teams, enhancing market competitiveness and digitalgrowth.
Talent Development
Leadership Training
Peking University Economic Management Training Program
The Company emphasizes the importance of knowledge management and experience sharing by inviting expertsand key professionals to conduct thematic sharing sessions across diverse domains. These initiatives not onlyfacilitate the effective circulation and accumulation of institutional knowledge but also stimulate employees'innovative thinking and learning capabilities through systematic intellectual asset transfer.
During the Reporting PeriodHeld 6 Internal Knowledge Sharing Sessions, Reaching Nearly 500 Participants
Internal Knowledge Sharing
EffectiveCommunication inthe Workplace
020406
0305
Role Transition andProfessional Competenciesfor R&D Engineers
Ultra-PrecisionProcessingTechniques
BusinessNegotiationSkillsFundamentals ofOphthalmologyProject Managementand Practices inInnovative MedicalDevice Development
5253
The Company places great importance on onboardingnew employees, establishing systematic trainingframeworks to accelerate their integration into theworkplace. In 2024, we updated the "OnboardingPlan" and "Knowledge Program" to help new hiresbetter understand company culture and regulations,deepening their recognition of our values andenhancing team belonging.
Eyebright Medical has established a tiered business enablement framework, and conducted Lean ProductionQuality Management Training to enhance decision-making.
We emphasize the enhancement of general skillsacross all employees. Based on talent assessments,we carefully select external online training resourcesand provide learning opportunities through onlineplatforms for both headquarters and subsidiaries.We also establish "learning groups" to encourageemployees to share personal insights, helping themimprove skills and broaden their perspectives.
New Employee TrainingGeneral Skills Training
During the Reporting Period, Training Overview
Total Sessions
Total Participants4,595
Total Duration
hours28,338
The Company prioritizes employee health management by adhering to legal requirements and offeringadditional benets such as supplementary medical insurance, health check-ups, annual leave, holiday gifts, andBeijing Household Registration Quotas. These diverse welfare measures enhance employee development, well-being, and overall sense of belonging.
The Company listens to employee voices, prioritizes fostering an open communication culture. We utilize variouschannels to understand employee needs for timely responses. Continuous process optimization and workenvironment improvements enhance employee satisfaction and foster a positive corporate culture.
Employee Benets
Democratic Communication
Pension insurance, Work InjuryInsurance, UnemploymentInsurance, Maternity Insurance,Medical Insurance
Supplementary Medical InsuranceAnnual Health Check-UpsSpecic Disease Screening for Female EmployeesEmployee Assistance Program (EAP)Holiday Gifts and Special BonusesFree Shuttle Bus, Nursing Rooms, and Gym FacilitiesHousing Provident FundStatutory Holidays and Paid Leave
Statutory Benets
Welfare and Care
Multi-ChannelCommunicationMechanisms
Employee Representative AssemblyEmployee Relations SpecialistsCorporate Newsletter:
Company Benets
Lean Production QualityManagement Training
English Language Training
Enhanced Internal AuditProfessional Training
Compliance Management
Training
Business Empowerment Training
5455
The Company prioritizes work-life balance by creating an employee-centered support system that addressesdiverse needs.
The Company embraces a "people-oriented" management philosophy, fostering a vibrant workplace throughdiverse activities that promote work-life balance. We enhance cultural identity and team cohesion throughmeaningful rituals, nurturing a caring and growth-oriented environment where employees nd happiness andgrow with the Company.
Work-Life Balance
To meet diverse needsWe have established nursing rooms for breastfeeding mothers, built basketball courts and gyms fortness enthusiasts, and provided shuttle services covering major residential areas and transport hubsto ease commuting.
Eyebright Medical WorldBook Day Initiative
Fourth EmployeePhotography Contest
Eyebright MedicalSports Day
2024 Team-Building Trip
Warmth and CareDuring Festivals
Co-Creation ofInterests and Values
ComprehensiveWell-Being Support
5657
Eyebright Medical prioritizes employee health by upholding the highest safety standards. We comply withrelevant laws, including the Safety Production Law, Occupational Disease Prevention Law, and more. Wecontinuously invest in safety management to provide a secure work environment. In March 2025, we achievedISO 45001 Occupational Health and Safety Management System certication.
Occupational Health
Occupational Health and Safety
The Company adheres to the principle of SafetyFirst, Prevention as Priority, and Holistic Governanceto strengthen safety responsibilities and enhanceoverall performance, effectively reducing workplaceaccidents and occupational diseases. We haveachieved Level 3 Certification in safety productionstandardization.
We prioritize safety education by regularly providingtraining on safety production, fire safety, andemergency escape to improve employee awarenessand skills.
Safety Production
Training on Safety Production
To standardize emergency responses, the Companyhas developed an “Emergency Response Plan forProduction Safety Incidents” for production safetyincidents, including comprehensive and specializedplans. We maintain emergency supplies and conductregular drills in re, chemical, and biological safetyto enhance our response capabilities and minimizerisks.
Emergency Management
HolisticGovernancePrevention as
PrioritySafety First
During the Reporting Period
Serious Workplace Accidents occurredNO
5859
Eyebright Medical views serving the communityas a fundamental responsibility. Committed toadvancing global eye health, the Company providescutting-edge ophthalmic technologies and activelysupports social initiatives. This includes medical aidto several countries, assistance for cataract patients,help for vulnerable groups, and myopia preventionawareness among children. These efforts showcasethe Company's dedication to social responsibility.
In 2024, in collaboration with Chinese medical teams,we helped ophthalmic patients in countries likeVenezuela, Equatorial Guinea, and Ethiopia restoreclear vision. This initiative signicantly contributes toglobal health efforts.
Serve the Society
International Aid Initiatives
Eyebright Medical actively supports the "HealthyChina", leveraging its strengths to provide grassrootsmedical aid.In 2024, we donated surgical supplies, includingintraocular lenses, viscoelastic, and reading glasses,to regions like Xichuan, Xixia, Neixiang in Henan,Gande in Qinghai, and other areas. These effortsdelivered sight to underprivileged patients.
Medical Donation
6061
Eyebright Medical, incollaboration with the ChinaCharity Federation, WeihaiCity Civil Affairs Bureau,and Weihai City CharityFederation, organized the"Eyebright AccompaniesYour Growth" in Weihai,Shandong. We donatedbackpacks, stationery,and sports equipment tounderprivileged children,bringing them holidaygifts and warm wishes onChildren's Day.
Eyebright Medical launched the "EyebrightAccompanies Your Growth—Warm Mid-AutumnFestival" charity event to support children withspecial needs. We delivered festive greetingsto kids at the Beijing Huicongshu RehabilitationEducation Research Institute, where leadersexpressed heartfelt gratitude for our ongoingsupport.
Eyebright Medical conducted a heartwarming NewYear care initiative at two specialized institutionsin Beijing. The Company provided daily necessitiesand educational supplies to the children,demonstrating its commitment to corporate socialresponsibility through tangible actions.
Public Welfare and Charity
During the Double Ninth Festival,Eyebright Medical partnered withthe Beijing Overseas ChineseService Center to host the "WarmDouble Ninth, Beautiful Life"service event. We distributed"Warm Double Ninth" carepackages to elderly members ofthe overseas Chinese community,conveying holiday greetings andenhancing their sense of well-being and happiness.
The Shanghai Charity Foundationlaunched the charity project, featuringthe inaugural "Health Science Outreachto Communities: Zero Distance Servicefor Seniors." Over 100 medical expertsserved elderly residents across 7 districtsand nearly 20 neighborhoods, promotinghealth care knowledge. Eyebright Medicalhas made signicant contributions.
Eyebright Medical, incollaboration with the BeijingOverseas Chinese CharityFoundation and other relatedorganizations, launched the"Overseas Chinese Care forFangshan—New Year Warmth"campaign. We provided carepackages to over 200 familiesin the Da’anshan Township ofFangshan District, spreadingwarmth in the New Year.
New Year Warmth Campaign
Service Activity for Overseas Chinese
Filial Piety and Respect for the Elderly Activity
Eyebright Accompanies Your Growth seriesDuring the Reporting Period
6263
Eyebright Medical visited Nanshao Middle Schoolin Changping District, Beijing, for the "EyebrightAccompanies Your Growth" event. We educatedstudents and teachers on eye health and myopiaprevention through lectures and outdoor activities,encouraging active participation in eye care andenhancing knowledge to protect their vision.
Science Popularization in Schools
Scientic Popularization
Eyebright Medical launched the theme event"Eyebright Accompanies Your Growth—Exploring theWonders of Vision and Illuminating the Window to theSoul." High school students from Beijing's ChangpingDistrict visited our headquarters to explore thefascinating world of ophthalmic medicine. Theyexperienced firsthand how technology safeguardshuman visual health.
Exploring Ophthalmic Medical Activities
Eyebright Medical, in collaboration with the BeijingDrug Administration's Fourth Branch, hosted the"Eyebright Accompanies Your Growth—First Lessonof School: Together for Eye Health" science openday at our headquarters. The event attracted manychildren, teens, and parents. Through engagingactivities, we promoted eye health awareness andhelped kids develop good eye care habits for thenew school year. Staff from the Drug Administrationshared knowledge on medical devices, guidingattendees on safe and healthy usage.
Back-to-School Science Exploration Day
Eyebright Medical and its subsidiary collaboratedwith local hospitals to host Eye Care Day activities inBeijing and Yantai, Shandong.In Beijing, we partnered with ophthalmology expertsfrom the Changping District Hospital to educateresidents on eye health and conducted vision andcataract screenings for middle-aged and elderlyindividuals, providing tailored treatment advice andhealth guidance based on their results.Eyebright Yantai collaborated with the PenglaiDistrict Disabled Persons' Federation and localophthalmologists to host Eye Care Day activities.We conducted eye health lectures and diseasescreenings in the community, providing residentswith convenient and comprehensive health servicesright at their doorstep.
Eye Care Day Series of Science Activities
Eyebright Medical participated in the Cultural,Science, and Health Outreach Event at XingshouSchool in Changping District. We showcased ourinnovative technologies in surgical treatment, myopiaprevention, and vision care, allowing local residentsto experience advanced ophthalmic technologyrsthand.
During the "Penglai Students Explore Hometown"event, over 30 Penglai students visited Eyebright(Yantai). Through immersive visits, students gainedin-depth insights into their hometown's cutting-edgeadvancements, and acknowledging the rapid andtransformative progress shaping their hometown.Committed to returning for employment andentrepreneurship, the students aim to contributetheir skills to the modernization of the new port city.
Beijing Cultural, Science, and Health Outreach Demonstration Event
Youth Talent Career Experience Day
Eyebright Accompanies Your Growth seriesDuring the Reporting Period
6465
2024 Environmental, Social and Governance Report2024 Environmental, Social and Governance Report
Governance
Eyebright Medical strictly complies with relevant laws,regulations, and normative guidelines in its corporategovernance. The Company continuously improvesits corporate structure, and standardizes internalcontrols and risk management systems, protectsrights and interests of shareholders and investors,upholds business ethics, prioritizes informationsecurity and privacy, and safeguards the Company’shigh-quality development.
66676667
Eyebright Medical continues to enhance its corporate governance structure, and operating mechanisms throughthe practice, and actively builds a governance system that aligns with the requirement of modern economicsystem and high-quality development. It continuously emphasizes compliance management and strengthenits legal governance and operations. In strict compliance with applicable laws and regulations, the Companyrigorously adheres to the principles of transparency and accountability in its information disclosure practices.Our governance practices emphasize the alignment of corporate value creation with investor protectionobjectives, ensuring equitable treatment of all stakeholders while upholding the sustainable interactions withthe capital markets.
The Company follows the Company Law, SecuritiesLaw, and STAR Market Listing Rules of the ShanghaiStock Exchange , as well as other relevant administrativeregulations and normative documents, maintaininga well-structured internal governance framework,comprising a General Meeting of Shareholders,Board of Directors, Supervisory Board, and SeniorManagement. The board of directors comprisesnine members, including six Non-IndependentDirectors and three Independent Directors. TheBoard is responsible for leading and overseeingthe Company’s business operations, strategicplanning, and internal organizational structure,and has established the Audit Committee, StrategyCommittee, Compensation and AssessmentCommittee, and Nomination Committee. All membershave relevant industry experience, professionalknowledge and regularly participate in various typesof training to improve their competencies.
General Manager’s Ofce
Board of Directors
Board ofSupervisors
General Meeting of Shareholders
Corporate Governance
Governance Structure
Board Operation
Eyebright Medical continuously establishes a robust management mechanism comprising the " ThreeGovernance Bodies and Senior Management." The Company has further revised internal controlsystems, including the Articles of Association, Rules of Procedure for the Board of Directors , InternalAudit Management Regulations, and the Operational Guidelines for the Board Audit Committee, and hasformulated the Work Guidelines for Independent Directors. Independent directors are required to submitthe Independence Self-Assessment Report to the Board of Directors annually. The board evaluates thereports and issues a Special Assessment Report, ensuring that the independent directors meet regulatoryrequirements on independence, thereby ensuring robust and effective corporate governance.
The Company is committed to promoting board diversity based on the Company’s developmentneeds. In selecting board members, the Company fully considers various factors such as gender, age,expertise, academic level, and education background. Drawing upon their diverse professional expertiseand industry-specific knowledge, board members deliver informed perspectives and well-foundedrecommendations that enhance the Company's governance framework and strategic oversight.
The board includes four specialized committees—Strategic Committee, Audit Committee, NominationCommittee, and Compensation and Assessment Committee. These committees operate under Boarddelegation with defined operational mandates, executing governance responsibilities with professionalrigor and ethical integrity. Members maintain rigorous meeting attendance, engage in systematic reviewof management reports, and conduct robust oversight through critical evaluation processes. Theirstructured advisory input ensures Board deliberations incorporate multidimensional expertise, therebyenhancing decision-making quality and governance efcacy.
Eyebright Medical continues to strengthen the roles of the shareholders' meeting, board of directors, andboard of supervisors to ensure effective decision-making, management, and oversight. Their collaborationpromotes scientic, efcient, and transparent processes for major decisions and compliance, safeguardingthe Company’s stable development and regulatory compliance. During the reporting period, the board ofdirectors, supervisory board, and shareholders' meetings strictly adhered to statutory obligations underthe Company Law and Securities Law, with all convening procedures, participant eligibility criteria, andvoting mechanisms demonstrating full compliance with regulatory requirements.
Independence
Diversity
Specialization
Effectiveness
During the reporting period
board meetings with 47 proposals approvedboard committees meetings with 40proposals approved
supervisory committee meetings with 36proposals approvedshareholders' meeting with 11 proposalsapproved
Strategy Committee
Audit Committee
Compensation andAssessment CommitteeNomination Committee
6869
The Company prioritizes the concerns of marketparticipants, and strives to build a bridge of trustto ensure a fair and objective understanding ofits strategy and operations, thereby enhancingconfidence in its future development. TheCompany has established the Investor RelationshipManagement System, which clearly defines theprinciples, organization methods for investor relationsactivities. Through rigorous execution of this system,the Company strives to build a mutually trusting andharmonious investor relations framework.The Company engages with investors throughmultiple channels, including dedicated investorhotline, IR email, and the SSE E-Interaction platform,providing timely and comprehensive responsesto inquiries regarding corporate operations,management, and business development. It alsolistens attentively to investor opinions, ensurestheir rights to information, accurately conveysthe Company’s value, and strengthens investorcondence.
Investor Relations ManagementInvestor Communication
During the Reporting Period
Held Earning Conference Call
The Company emphasizes two-way communicationwith institutional investors and analysts through 6performance briefings and events such as "ListedCompanies Enter Hong Kong – Investor Exchange”and “Discover New Opportunities in Investing inChina." These efforts aim to enhance its capitalmarket image and foster a positive valuation system.
During the Reporting Periodresearch reports and performance reviews,assigning ratings such as " " and " ."Over nancial institutions published nearly
The Company follows STAR Market Listing Rules ofthe Shanghai Stock Exchange and other relevantlaws, as well as the provisions of its InformationDisclosure Management System, to conductinformation disclosure operations. It enhanceseffective management of information disclosure andstrengthens its authenticity, accuracy, completeness,timeliness, and compliance. It aims to improvedisclosure quality and protect all shareholders,particularly minority ones, receiving the highest Arating in the Shanghai Stock Exchange (SSE) AnnualInformation Disclosure Work Evaluation for twoconsecutive years.
Information Disclosure
The Company convenes shareholders' meetingslawfully, safeguarding shareholders' rights toinformation, participation, inquiry, and voting. Itactively solicits investor feedback on corporategovernance and sustainable development initiatives.Through initiatives such as the “Financial EducationAwareness Month”, the Company enhancesinvestors’ understanding of market rules, risks, andopportunities, strengthens risk prevention awareness,and fosters a culture of value-driven and long-terminvestment.
Investor Protection
20+
BuyHold
7071
Eyebright Medical places great emphasis on marketvalue management, adhering to the requirementsof the Guidelines for Listed Company SupervisionNo.10–Market Value Management, the Company shalllegally and comprehensively utilize diversied marketvalue management tools to ensure its investmentvalue rationally reects its quality.
Based on their confidence in the Company’s futuredevelopment trends and investment value, fromJune to December 2024, certain directors and seniormanagement conducted share purchases throughcentralized bidding transactions on the ShanghaiStock Exchange trading system.
In line with its development goals and funding needs,in October 2024, the Company initiated a simpliedprocess to issue shares to specic investors, aimingto raise up to RMB300 million, attracting stronginterest from both domestic and foreign investors.
In proactive response to the initiative of securitiesregulatory authorities, the Company released the2024 Quality Improvement and Effect EnhancementAction Plan to protect the investors’ rights andinterests and prioritize the investor achievement.In March 2025, the Shanghai Stock Exchangerecognized the Company's exemplary practices inshareholder value creation and investor relations asa demonstration case in several key areas, as part ofthe SSE’s “Best Practices Handbook for the SpecialAction on Quality and Returns”.
Chairman and controlling shareholder, the boardproposed a stock buyback using company funds.
In 2024, the Company implemented a distributionplan. It distributed RMB4.90 (before tax) in cashdividends for every 10 shares held and capitalizedcapital reserves to issue 8 additional shares for every10 shares held.
Market CapitalizationManagementInvestor Returns
2024
During the Reporting Period
During the Reporting Period
Total Cash Dividends
Total amount spent
Total Amount Purchased
Total Capitalization of Capital Reserves
Shares repurchased
Total Shares Purchased
Million
Million
Million
Million SharesRMB
RMB
RMB
51.5
20.04
3.44
84.09
142,800
45,109
The Company has established a risk management system, and continues to improve its internal control system,and adhered to a culture of integrity, pragmatism, fairness, justice and incorruptibility. By systematicallyenhancing the ethical competence of all personnel, we strive to achieve long-term, stable, healthy, andsustainable development.
Risk Management and Control
The Company places high priority on advancinginternal control and compliance system development.It has devised a comprehensive framework tailoredto the corporation. A dynamic update mechanismhas been set up to coordinate between compliance,legal affairs, and audit functions to regularly reviewand revise internal policies. Revisions are madein response to changes in laws, regulations, andsupervisory policies, as well as practical insightsgained from daily operations and managementpractices, guaranteeing the timeliness, effectivenessand applicability of the systems.The Company emphasizes the operationalization ofits compliance governance framework, and enhancesenterprise-wide compliance awareness through multi-dimensional measures. It has created a transparentplatform to share compliance policies and operationalprocedures with all employees, including those insubsidiaries, ensuring the consistency of policyimplementation. Additionally, a tiered training systemhas been established to conduct the regular sessionsfor improving compliance awareness and executioncapabilities. Moreover, the Company has openedup feedback channels to encourage employees tosuggest compliance improvements, thereby fosteringa participatory culture that supports long-termhealthy development.
Compliance and InternalControl Management
To ensure fairness, impartiality, and equitability inrelated party transactions, and to prevent controllingshareholders, actual controllers, and directors, andrelated personnel from harming the interests of theCompany and minority shareholders, the Companyhas formulated the Related Party TransactionDecision-Making System. The Company and itssubsidiaries strictly comply with the Company Law,the Securities Law, and the Articles of Associationto regulate related party transactions, ensuring thatno such transactions have harmed the interests ofminority shareholders. The Company follows therequired review and decision-making procedures.During deliberations on related-party transactionproposals, relevant parties abstained from votingto ensure fairness and reasonableness of suchtransactions.During the Reporting Period
Related Party Transactionsand Control
insider trading occurredinstances of shareholderrightsinfringement or corporate asset diversionNONO
7273
In the medical device industry, any quality or safety incidents related to the manufacturing, distribution, or saleof medical devices are prone to attract widespread media attention. To manage this risk, we have established aReputation Management System that addresses reputational risks in strategic planning, corporate governance,business operations, information disclosure, and employee management. This system enhances the abilityto manage reputational events by promptly identifying, assessing, monitoring, responding to, and reportingreputational risks, ensuring timely detection and response. This helps to minimize losses and negative impactson the Company, its stakeholders, and the industry, safeguard the Company’s brand value and corporate image,and promote sustainable, healthy, and stable development.
Analysis of Public Opinion
During the Reporting Period
Eyebright Medical upholds "Integrity and Practicality" as one of its core values, strictly following the laws andregulations like the Provisional Regulations on the Prohibition of Commercial Bribery, and adheres to highstandards of business ethics. It has established a supervision team to prevent commercial bribery and set up areporting hotline, creating a collaborative anti-bribery oversight mechanism.We actively conduct trainings on the business ethics and anti-fraud, and the training on the Code of Conduct,focusing on professional conduct and anti-bribery, and related topics, supporting by use case studies. Trainingsalso reinforce understanding of internal regulations like the Employee Code of Conduct, the Gift AcceptanceManagement Policy, and Whistleblowing Policy, ensuring clear reporting processes and strengthening anti-frauddefenses.The Company integrates business ethics oversight into daily operations and emphasizes employee integrityduring audits to prevent and detect fraud risks. Internal reporting channels are kept open and independentfor anonymous tip-offs, and investigations are carried out objectively and fairly while strictly maintainingcondentiality to protect whistleblower rights.
Anti-Fraud and Anti-Corruption Measures
During the Reporting Period
Eyebright Medical promotes a fair marketenvironment by strictly adhering to the Anti-UnfairCompetition Law, the Anti-Monopoly Law of PRC, andother relevant regulations to prevent any occurrenceof unfair competition. The Company requires allemployees to maintain integrity and fairness ininteractions with competitors, customers, andsuppliers, ensuring truthful product representation.
Anti-Competitive Practices
Eyebright Medical has institutionalized acomprehensive whistleblowing framework alignedwith global compliance standards. The Companyenforces stringent whistleblower protection protocolsto safeguard identities and reported contentthrough multilayered confidentiality safeguards. Allsubmissions via dedicated hotlines, secured email, orpostal services undergo triaged case management toensure impartiality and traceability.
Reporting Mechanism
Reporting Channels
（
）10-60745730 contact@ebmedical.com
The Company prioritizes information security andprivacy protection by enforcing comprehensivenetwork and computer management policies andbuilding a comprehensive and efficient informationsystem, thereby establishing a sound informationsecurity and privacy protection managementframework. The framework is designed tocomprehensively safeguard the data security andconfidentiality, effectively mitigate informationsecurity risks, and ensure stable and sustainableoperations.
Information Security
Information Security and Privacy ProtectionPartner Information Security ManagementPhysical Access Control
signicant reputation-related issues or media inquiriesNO
related issues were reportedsignicant corruption incidents occurredNONO
During the Reporting Period
unfair competition lawsuits occurredNO
7475
GRI Standards DisclosureItem Number
GRI 2-1GRI 2-2GRI 2-3GRI 2-4GRI 2-5GRI 2-6GRI 2-7GRI 2-8GRI 2-9GRI 2-10GRI 2-11GRI 2-12GRI 2-13GRI 2-14GRI 2-15GRI 2-16GRI 2-17GRI 2-18GRI 2-19GRI 2-20GRI 2-21GRI 2-22GRI 2-23GRI 2-24GRI 2-25GRI 2-26GRI 2-27GRI 2-28
GRI Standards DisclosureItem NameOrganization DetailEntities Including in the Organization’s Sustainability ReportingReporting Period, Frequency and Contact PointRestatements of InformationExternal AssuranceActivities, Values Chain and other business RelationshipsEmployeeNon-employee workersGovernance Structure and CompositionNomination and Selection of the Highest Governance bodyChair of the Highest Governance BodyRole of the Highest Governance Body in Overseeing theManagement of ImpactsDelegation of Responsibility forManaging ImpactsRole of the Highest Governance Body in Sustainability ReportingConict of InterestCommunication of critical concernsCollective knowledge of the highest governance bodyEvaluation of the performance of the highest governance bodyRemuneration PoliciesProcess to determine remunerationAnnual Total Compensation RatioStatement on Sustainable Development StrategyPolicy CommitmentEmbedding Policy CommitmentsProcesses to Remediate Negative ImpactsMechanisms for Seeking Advice and Raising ConcernsCompliance with Laws and RegulationsMembership Associations
General DisclosureGRI2：
General Disclosures
GRI2：
Activities and Workers
GRI2：
Governance
GRI2：
Strategy, Policies and Practices
Report Section
About the ReportAbout the ReportAbout the Report/Board StatementAbout UsEmployee Development/Corporate GovernanceCorporate GovernanceCorporate GovernanceCorporate GovernanceCorporate GovernanceBoard StatementStakeholder CommunicationStakeholder CommunicationCorporate GovernanceCorporate GovernanceCorporate Governance//ESG Strategy PlanningPollution Prevention, EmployeeDevelopment, Corporate GovernanceEmployee DevelopmentRisk ManagementStakeholder CommunicationRisk ManagementCollaborative Advancement in the Industry
Appendix
GRI 2-29GRI 2-30GRI 3-1GRI 3-2GRI 3-3
GRI 201-1GRI 201-3GRI 201-2
GRI 301-2GRI 301-3GRI 302-1GRI 302-3GRI 302-4GRI 302-5
GRI 203-1GRI 203-2GRI 205-1GRI 205-2
GRI 206-1
Approach to Stakeholder EngagementCollective Bargaining AgreementsProcess to Determine Material TopicsList on Material TopicsManagement on Material Topics
Direct Economic Value Generated and DistributedDened Benet Plan Obligations and Other Retirement PlansFinancial Implications and Other Risks and Opportunities dueto Climate Change
Recycled Input Materials UsedReclaimed Products and Their Packaging MaterialsEnergy Consumption within the OrganizationEnergy IntensityReduction of Energy ConsumptionReductions in Energy Requirements of Products and Services
Infrastructure Investments and Services SupportedSignicant Indirect Economic ImpactsOperations Assessed for Risks Related to CorruptionCommunication and Training About Anti-Corruption Policiesand Procedures
GRI 206-1 Legal Actions for Anti-Competitive Behavior, Anti-trust, and Monopoly Practices
GRI2：
Stakeholder Engagement
GRI201：
Economic Performance
GRI301：
Materials
GRI302：
Energy
GRI203：
Indirect Economic Impacts
GRI205：
Anti-Corruption
GRI2016：
Anti-Competitive Behavior
Topic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosures
Risk Management
Risk Management
Risk Management
Risk Management
GRI3：
Material Topics
Stakeholder CommunicationEmployee DevelopmentMateriality AssessmentMateriality AssessmentMateriality Assessment
Corporate GovernanceEmployee DevelopmentClimate Action
//Resources ManagementResources ManagementResources ManagementResources Management
Serve The SocietyServe The Society/
/
Risk Management
Economic
Environmental
GRI Standards DisclosureItem Number
GRI Standards DisclosureItem NameGeneral Disclosure
Report Section
7677
GRI 303-1GRI 303-2GRI 303-3GRI 303-4GRI 303-5
Interactions with Water as a Shared ResourceManagement of Water Discharge Related impactsWater WithdrawalWater DischargeWater Consumption
GRI303：
Water and Efuents
Resources ManagementResources ManagementResources ManagementPollution PreventionResources ManagementGRI 305-1GRI 305-2GRI 305-4
GRI 308-1GRI 308-2
GRI 403-1GRI 403-2
GRI 401-1GRI 401-2
GRI 306-1GRI 306-2GRI 306-3GRI 306-4GRI 306-5
GRI 305-7 /
Direct (Scope 1) GHG EmissionsEnergy Indirect (Scope 2) GHG EmissionsOther Indirect (Scope 3) GHG EmissionsNitrogen Oxides (NOx), Sulfur Oxides (SOx), and OtherSignicant Air Emissions
New Suppliers that were Screened Using EnvironmentalCriteriaNegative Environmental Impacts in the Supply Chain andActions Taken
Occupational Health and Safety Management SystemHazard Identication, Risk Assessment, and IncidentInvestigation
New Employee Hires and Employee TurnoverBenets Provided to Full-Time Employees that are not Providedto Temporary or Parttime Employees
Waste Generation and Signicant Waste-Related ImpactsManagement of Signicant Waste Related ImpactsWaste GeneratedWaste Diverted from DisposalWaste Directed to Disposal
Environmental
Social
GRI305: Emissions
GRI308：
Supplier Environmental Assessment
GRI403：
Occupational Health and Safety
GRI401：
Employment
GRI402：
Labor/Management Relations
GRI306：
Waste
/Climate ActionClimate Action
//
Employee DevelopmentEmployee Development
Employee DevelopmentEmployee Development
Pollution PreventionPollution PreventionPollution Prevention//
Topic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosuresTopic management disclosures
Climate Action
Product Responsities
Employee Development
Employee DevelopmentEmployee Development
GRI Standards DisclosureItem Number
GRI Standards DisclosureItem Name
Report Section
GRI 405-1
GRI 406-1
GRI 408-1
GRI 407-1
Diversity of Governance Bodies and Employees
Incidents of Discrimination and Corrective Actions Taken
Operations and Suppliers at Signicant risk for Incidents ofChild Labor
Operations and Suppliers in which the right to freedom ofAssociation and Collective Bargaining may be at Risk
GRI405:Diversity and Equal Opportunity
GRI406:Non-Discrimination
GRI408:Child Labor
GRI407 :Freedom of Association and Collective Bargaining
Employee Development,Corporate governance
Employee Development
/
/
SocialGRI Standards DisclosureItem Number
GRI Standards DisclosureItem Name
Report Section
GRI403：
Occupational Health and SafetyTopic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosuresTopic management disclosures
Topic management disclosures
Employee Development
Employee Development
Employee Development
Employee DevelopmentEmployee Development
Employee Development
GRI 403-3GRI 403-5GRI 403-6
GRI 403-9GRI 403-10
GRI 403-4
GRI 403-7GRI 403-8
Occupational Health ServicesWorker Training on Occupational Health and SafetyPromotion of Worker Health
Work-Related InjuriesWork-Related Ill Health
Worker Participation, Consultation, and Communication onOccupational Health and Safety
Prevention and Mitigation of Occupational Health and safetyImpacts Directly Linked by Business RelationshipsWorkers Covered by an Occupational Health and SafetyManagement System
Employee DevelopmentEmployee DevelopmentEmployee Development
Employee DevelopmentEmployee Development
Employee Development
Employee DevelopmentEmployee Development
GRI404:Training and EducationGRI 404-1
GRI 405-2
GRI 404-2GRI 404-3
Average Hours of Training per Year per Employee
Ratio of Basic Salary and Remuneration of Women to Men
Programs for Upgrading Employee Skills and TransitionAssistance ProgramsPercentage of Employees Receiving Regular Performance andCareer Development Reviews
Employee Development
Employee Development
Employee DevelopmentEmployee Development
7879
GRI 414-1GRI 414-2
GRI 409-1
New Suppliers that were Screened using Social CriteriaNegative Social Impacts in the Supply Chain and Actions Taken
Operations and Suppliers at Signicant risk for Incidents ofForced or Compulsory Labor
GRI414：
Supplier Social Assessment
GRI413：
Local Community
GRI416：
Customer Health and Safety
GRI417：
Marketing and Labeling
GRI418：
Customer Privacy
GRI409：
Forced or Compulsory Labor
Product Responsibility/
Topic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosures
Topic management disclosures Product Responsibility
Serve The Society
Product Responsibility
Product Responsibility
Product Responsibility
Social
GRI Standards DisclosureItem Number
GRI Standards DisclosureItem Name
Report Section
GRI 413-1
GRI 416-1
GRI 417-1
GRI 418-1
GRI 413-2
GRI 416-2
GRI 417-2GRI 417-3
Operations with Local Community Engagement, ImpactAssessments, and Development Programs
Assessment of the Health and Safety Impacts of Product andService Categories
Requirements for Product and Service Information andLabeling
Substantiated Complaints Concerning Breaches of CustomerPrivacy and Losses of Customer Data
Operations with Signicant Actual and Potential NegativeImpacts on Local Communities
Incidents of Non-Compliance Concerning the Health and SafetyImpacts of Products and Services
Incidents of Non-Compliance Concerning Product and ServiceInformation and LabelingIncidents of Non-Compliance Concerning MarketingCommunications
Serve The Society
Product Responsibility
Product Responsibility
/
/
/
//
/